Recently, hypoadrenalism was described in extremely low birth weight infants. We have been measuring serum cortisol levels in very low birth weight (VLBW) infants to assess their adrenal function. It was noticed that infants of substance-abusing mothers (ISAM) had unusually high serum cortisol levels. To our knowledge, there are no data regarding serum cortisol levels in VLBW ISAM. The objective of our study was to determine if serum cortisol levels of VLBW ISAM are different from serum cortisol levels in VLBW infants without a history of maternal substance abuse.
Recently, hypoadrenalism was described in a group of extremely low birth weight infants. 1 This group of infants presented with persistent severe hypotension, metabolic acidosis, and oliguria unresponsive to volume expanders and maximal inotropic support. Despite undergoing significant stress, their serum cortisol levels were very low. After administration of hydrocortisone, their blood pressure, acidosis, and oliguria improved dramatically. Based on this information, in our Neonatal Intensive Care Unit (NICU), we often measure postnatal serum cortisol levels in VLBW infants to assess their adrenal function. It was observed that infants of substance-abusing mothers (ISAM) had unusually high serum cortisol levels. It is known in adults that cocaine administration increases serum cortisol levels. 2 In animals, maternal cocaine administration can stimulate the fetal pituitaryadrenal axis and result in increased fetal serum cortisol levels. 3 Chronic heroin abuse has been reported to cause hypoadrenalism, 4 whereas abrupt discontinuation of heroin resulted in elevated cortisol production. 5 To our knowledge, in VLBW ISAM, data regarding serum cortisol levels early in life have not been reported. The purpose of our study was to determine if serum cortisol levels in VLBW ISAM are different from cortisol levels in infants without exposure to illicit drugs.
MATERIALS AND METHODS
We reviewed medical records of all infants with birth weight between 400 and 1300 gm who were admitted to the NICU of Women's and Children's Hospital, Los Angeles County and University of Southern California Medical Center between July 1994 and June 1995. Serum cortisol levels are often obtained in VLBW infants admitted to our NICU as part of clinical care. A serum cortisol level obtained under stress should reflect the patient's hypothalamic-pituitary-adrenal function. Thus the cortisol levels are used as adjunctive information in making a decision whether to treat or not the infants with corticosteroids. After identifying VLBW infants who had serum cortisol levels obtained in the first 48 hours of life, clinical characteristics and clini-Original Article
cal outcome data of the infants were collected. Clinical characteristics data included maternal age, prenatal care, preterm labor, prolonged rupture of membranes (more than 24 hours), history of chorioamnionitis, history of preeclampsia, mode of delivery, fetal presentation, antenatal steroid therapy, history of substance abuse, birth weight, gestational age, Apgar scores, respiratory support, surfactant use, heart rate and mean blood pressure at the time of cortisol levels, and vasopressor drug use in the first 24 hours. Clinical outcome data included survival, cause of death, days on mechanical ventilation, days on oxygen supplementation, and length of hospital stay. ISAM were identified by either maternal history of substance abuse and/or infants' positive urine drug screening. All women who were seen at the Prenatal Clinic and who were admitted to the Labor and Delivery Floor were routinely asked about substance abuse history. Control infants were selected from VLBW infants who had serum cortisol levels obtained in the first 48 hours of life but who had a negative urine drug screening and no history of maternal substance abuse. Infants in the ISAM and control groups were matched for gestational age, maternal antenatal steroids, and birth weight. Clinical characteristics, serum cortisol levels, and clinical outcome were compared between the two groups.
Serum cortisol levels were measured by radioimmunoassay (Coat-A-Count Cortisol; Diagnostic Products Corp., Los Angeles, CA). This method has very low cross-reactivity to other naturally occurring steroids. The intra-assay coefficient of variation ranged from 4% to 6%, and the interassay coefficient of variation ranged from 3% to 5%. Assay sensitivity was 0.5 g/dl (1 g/dl cortisol ϭ 27.59 nmol/l).
A urine drug screening was performed with an enzyme immunoassay method (Emit II; Syva Co., San Jose, CA) with detection limits as follows: d-methamphetamine (1000 ng/ml), cannabinoid (50 ng/ ml), phencyclidine (25 ng/ml), methadone (300 ng/ml), opiates (300 ng/ml), and benzoylechonine (300 ng/ml).
Statistical significance between the groups was analyzed by twotailed paired Student's t tests for continuous variables. For discrete variables, the binomial distribution was used to determine statistical significance between the two groups using the probability found in the control group as the expected probability. The level of significance was set at p Ͻ 0.05.
RESULTS

Clinical Characteristics
There were 119 infants with birth weight between 400 and 1300 gm admitted to our NICU during the study period. Sixty-one patients (51.2%) had serum cortisol levels in the first 48 hours. Fifteen infants were identified as ISAM and seven of them had serum cortisol levels in the first 48 hours of life. Table 1 shows the clinical characteristics of the ISAM infants who had cortisol levels in the first 48 hours and the control infants. Between the groups, clinical characteristics observed were similar except for the prenatal care and chorioamnionitis. Significantly fewer infants in the ISAM group received prenatal care and significantly more infants in the ISAM group had chorioamnionitis.
The heart rate and mean blood pressure at the time of obtaining the cortisol levels were not statistically different between groups. Figure 1 shows mean serum cortisol levels Ϯ SEM in each group of infants. The mean serum cortisol level in the ISAM group was significantly higher than that of the control group (65.3 Ϯ 17.4 g/dl vs 20.5 Ϯ 7.5 g/dl, p ϭ 0.01). The median values for serum cortisol were 61.8 and 12.4 g/dl in the ISAM and control groups, respectively. Table 2 shows individual data of serum cortisol levels in the ISAM (three infants tested positive for cocaine, three for heroin, and one for both cocaine and heroin) and the control groups. The serum cortisol level of all but one patient in the ISAM group was higher than that of the control infants. All serum cortisol levels in the ISAM group except one were Ն30 g/dl. However, all serum cortisol levels in the control group except one were Ͻ30 g/dl. Table 3 demonstrates the clinical outcome of the ISAM and the control infants. There was one death in each group (patient number 1 in each group). Both of these patients were infants of 22 weeks' gestation who had congenital sepsis. Number of days on oxygen supplementation, duration of mechanical ventilation, and length of hospital stay were not significantly different between the two groups.
Serum Cortisol Levels
Clinical Outcome
DISCUSSION
There are several factors that may affect serum cortisol levels. Gestational age is a major factor that affects cortisol levels pre-and postnatally. Cord blood cortisol levels increase with increased gestation. 6 Cord blood cortisol levels in preterm infants (27 to 32 weeks' gesta- tion) are lower than those in full term infants. 7 However, in one study of premature infants with gestational age between 24 and 35 weeks, postnatal serum cortisol levels were found to be inversely related to gestational age. 8 Antenatal steroid therapy can cause transient adrenal suppression in the fetuses. Cord blood cortisol levels of newborns who had antenatal steroid therapy were found to be lower than in those who were not exposed to antenatal steroids. 9 Stress during delivery and postnatal stress may affect serum cortisol levels. Newborns delivered vaginally had higher serum cortisol levels than those who were delivered by cesarean section, 10, 11 and umbilical cord plasma cortisol levels were higher after breech than vertex delivery. 11 In previous studies, premature infants with severe respiratory distress syndrome had lower cord blood cortisol levels 7 but higher postnatal plasma cortisol levels than premature infants without respiratory distress syndrome, 12 indicating that their adrenal glands may be responsive to stress. However, in a more recent study, 8 postnatal plasma cortisol levels of sick preterm infants were lower than in well preterm infants. It was speculated that they had adrenal insufficiency.
We have shown in this study that serum cortisol levels in VLBW infants are significantly higher in the ISAM group than in the control group. Confounding factors were controlled by matching the ISAM group and the control group for gestational age, birth weight, and antenatal steroid therapy. Other factors that may affect serum cortisol levels were also compared. There were no differences in mode of delivery, fetal presentation, history of preterm labor, and severity of respiratory illness. The ISAM group had a higher incidence of maternal chorioamnionitis than the control infants, but the incidence of proven perinatal sepsis was not different between the two groups (1 of 7 vs 1 of 7; p ϭ 1.0). Therefore, maternal substance abuse (cocaine and heroin) seems to be an independent factor that has a significant effect on postnatal serum cortisol levels of VLBW infants.
There are numerous reports on serum cortisol levels in premature infants. [13] [14] [15] All show that a majority of premature infants have low serum cortisol levels (Table 4) . This is thought to be due to an inadequate hypothalamic-pituitary-adrenal response to stress in premature infants. The mechanism of this is not clear. In our study, all but one patient in the ISAM group appeared to have adequate serum cortisol levels (Ͼ30 g/dl).
Cocaine has been shown to increase serum cortisol levels in healthy adults.
2 Although the precise mechanism is uncertain, it was thought to be a direct stimulating effect of cocaine on the hypothalamic-pituitary-adrenal axis. Another possible mechanism is that the increased serum cortisol level is a result of increased serum catecholamines from cocaine. Maternal cocaine administration can affect the fetal pituitary-adrenal axis. After injection of a single dose of cocaine (2 mg/kg) to pregnant ewes, both fetal plasma adrenocor- ticotrophic hormone (ACTH) and cortisol levels increased significantly. 3 However, direct cocaine injection to fetal lambs affected serum ACTH and cortisol levels to a lesser degree. 16 It seems that maternal and/or placental factors may have roles in the effect of cocaine on fetal serum cortisol levels. Maternal cocaine abuse may have longterm effects on adrenal function of newborns. In one study, the adrenal response to stress in premature infants of cocaine-abusing mothers was found to be blunted before discharge. 17 It was thought to be secondary to adrenal exhaustion.
The effects of heroin on the fetal and newborn pituitary-adrenal axis are unknown. In adults, chronic heroin use results in low basal serum cortisol levels and decreased response to an ACTH stimulation test. 4 Nevertheless, rapid discontinuation of heroin caused an increase in salivary cortisol levels. 5 In the fetus exposed to heroin throughout the pregnancy, it is conceivable that abrupt discontinuation of heroin supply from the mother after delivery will lead to an increase in serum cortisol levels. The long-term effects of maternal heroin abuse on the newborn pituitary-adrenal axis are also unknown.
It has been reported that ISAM had less severe lung disease when compared with control infants. 18 In utero exposure to cocaine can enhance lung maturation of fetal rabbits. 19 It was speculated that lung maturation in the prenatal cocaine-exposed rabbits was related to increased cortisol levels. In our study, the ISAM group had a shorter duration of oxygen supplementation, mechanical ventilation, and hospital stay, but the difference did not reach significance probably due to small sample size. Other possible clinical implications of our findings are: maternal substance abuse may have long-term effects on adrenal function in VLBW infants, and studies concerning cortisol levels in newborns should take maternal substance abuse into account.
CONCLUSION
Maternal substance abuse significantly increases serum cortisol levels in VLBW infants. Further studies on a larger scale are needed to confirm these findings, to delineate the mechanism and the long-term effects of maternal substance abuse on adrenal function, and to correlate the increased serum cortisol levels with the clinical outcome.
